1. Home
  2. DMRC vs BDSX Comparison

DMRC vs BDSX Comparison

Compare DMRC & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digimarc Corporation

DMRC

Digimarc Corporation

HOLD

Current Price

$4.69

Market Cap

117.8M

Sector

Technology

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$14.87

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMRC
BDSX
Founded
2008
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.8M
122.0M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
DMRC
BDSX
Price
$4.69
$14.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$10.00
$32.50
AVG Volume (30 Days)
272.0K
131.3K
Earning Date
03-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
18.58
N/A
EPS
N/A
N/A
Revenue
$25,213,000.00
$88,499,000.00
Revenue This Year
N/A
$25.26
Revenue Next Year
N/A
$19.70
P/E Ratio
N/A
N/A
Revenue Growth
15.69
24.08
52 Week Low
$4.07
$0.25
52 Week High
$14.64
$20.21

Technical Indicators

Market Signals
Indicator
DMRC
BDSX
Relative Strength Index (RSI) 41.20 48.80
Support Level $4.07 $6.33
Resistance Level $7.10 $20.21
Average True Range (ATR) 0.64 1.49
MACD -0.12 -0.54
Stochastic Oscillator 12.64 8.41

Price Performance

Historical Comparison
DMRC
BDSX

About DMRC Digimarc Corporation

Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: